A coincidence or a rare occurrence? A case of plasmablastic lymphoma of the small intestines following infliximab treatment for Crohn's disease

Ann Hematol. 2016 Jan;95(1):149-150. doi: 10.1007/s00277-015-2497-6. Epub 2015 Sep 12.

Authors

Su Wai Maung¹, Ronan Desmond², Johnny McHugh², Barbara Ryan³, Paul Neary⁴, Michael Jeffers⁵, Helen Enright²

Affiliations

¹ Department of Haematology, Tallaght Hospital, Tallaght, Dublin 24, Ireland. [email protected].
² Department of Haematology, Tallaght Hospital, Tallaght, Dublin 24, Ireland.
³ Gastroenterology, Tallaght Hospital, Dublin, Ireland.
⁴ Surgery, Tallaght Hospital, Dublin, Ireland.
⁵ Cellular Pathology, Tallaght Hospital, Dublin, Ireland.

PMID: 26361950
DOI: 10.1007/s00277-015-2497-6

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Crohn Disease / diagnosis
Crohn Disease / drug therapy*
Humans
Infliximab / adverse effects*
Intestine, Small / pathology*
Male
Middle Aged
Plasmablastic Lymphoma / chemically induced*
Plasmablastic Lymphoma / diagnosis*
Treatment Outcome
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Tumor Necrosis Factor-alpha
Infliximab